HANDOK Inc. (KRX:002390)

South Korea flag South Korea · Delayed Price · Currency is KRW
9,520.00
-110.00 (-1.14%)
May 15, 2026, 12:25 PM KST
Market Cap123.54B -20.4%
Revenue (ttm)535.14B +5.5%
Net Income-2.15B
EPS-162.00
Shares Out12.99M
PE Ration/a
Forward PEn/a
Dividend200.00 (2.09%)
Ex-Dividend DateFeb 26, 2026
Volume11,548
Average Volume34,615
Open9,630.00
Previous Close9,630.00
Day's Range9,350.00 - 9,680.00
52-Week Range9,380.00 - 13,460.00
Beta0.34
RSI33.26
Earnings DateMay 20, 2026

About HANDOK

HANDOK Inc. operates as a pharmaceutical company. The company provides prescription and OTC drugs; medical devices, such as blood pressure monitors, cholesterol monitoring systems, insulin pumps, self-monitoring system of blood glucose, and blood glucose monitoring system; in vitro diagnostic medical devices; as well as life science products. It also offers healthcare products comprising food supplements under the NatureSet brand; food and beverages; and medical nutrition products. In addition, the company engages in real estate leasing. The co... [Read more]

Sector Healthcare
Founded 1954
Employees 940
Stock Exchange Korea Stock Exchange
Ticker Symbol 002390
Full Company Profile

Financial Performance

In 2025, HANDOK's revenue was 535.14 billion, an increase of 5.48% compared to the previous year's 507.36 billion. Losses were -2.15 billion, -95.90% less than in 2024.

Financial Statements